As tens of thousands were dying of opioid overdoses, McKinsey worked with Purdue and the Sackler family on strategies to “turbocharge” OxyContin sales.
They planned counter strategies against drug enforcement agents - and against mothers of o/d victims.
nytimes.com/2019/02/01/bus…
They planned counter strategies against drug enforcement agents - and against mothers of o/d victims.
nytimes.com/2019/02/01/bus…
The above article is from Feb, 2019, but new information has recently come to light with more details.
Recall that originally, McKinsey initially tried to hedge on the extent of their involvement, making claims that implied the information may be 2nd- and 3rd-hand & unreliable.
Recall that originally, McKinsey initially tried to hedge on the extent of their involvement, making claims that implied the information may be 2nd- and 3rd-hand & unreliable.
But today, we learn damning details exposing the advice that McKinsey offered the Sacklers - even suggesting that Purdue could offer pharmacies/distributors *rebates* for every overdose, to give them incentives to continue selling OxyContin.
nytimes.com/2020/11/27/bus…
nytimes.com/2020/11/27/bus…
In 2018, as writing splashed on the wall suggesting legal culpability for Purdue, senior McKinsey partners discussed having a chat with their risk committee about whether they should be doing anything - besides “eliminating all our documents and emails.”
nytimes.com/2020/11/27/bus…
nytimes.com/2020/11/27/bus…
Why would McKinsey want to eliminate documents and emails?
Maybe because they didn’t want the public to see the cold, heartless dollar amount that they were assigning to overdoses, and to people who “develop an opioid use disorder.”
That McKinsey dollar amount:
$14,810.
Maybe because they didn’t want the public to see the cold, heartless dollar amount that they were assigning to overdoses, and to people who “develop an opioid use disorder.”
That McKinsey dollar amount:
$14,810.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
